Pages that link to "Q85010396"
The following pages link to CXCR4 peptide antagonist inhibits primary breast tumor growth, metastasis and enhances the efficacy of anti-VEGF treatment or docetaxel in a transgenic mouse model (Q85010396):
Displaying 49 items.
- Antagonist antibodies to vascular endothelial growth factor receptor 2 (VEGFR-2) as anti-angiogenic agents (Q26747054) (← links)
- CXCR4 in breast cancer: oncogenic role and therapeutic targeting (Q26781915) (← links)
- Use of rodents as models of human diseases (Q26822856) (← links)
- CXCR4/CXCL12 in non-small-cell lung cancer metastasis to the brain (Q27009526) (← links)
- CXCL12 modulation of CXCR4 and CXCR7 activity in human glioblastoma stem-like cells and regulation of the tumor microenvironment (Q33677057) (← links)
- Inhibition of CXCL12/CXCR4 axis as a potential targeted therapy of advanced gastric carcinoma (Q33775283) (← links)
- CXCL12/CXCR4 blockade by oncolytic virotherapy inhibits ovarian cancer growth by decreasing immunosuppression and targeting cancer-initiating cells (Q34476278) (← links)
- Small molecule inhibitors of CXCR4. (Q34574987) (← links)
- Blockade of CXCL12/CXCR4 signaling inhibits intrahepatic cholangiocarcinoma progression and metastasis via inactivation of canonical Wnt pathway (Q34694101) (← links)
- Breast cancer at bone metastatic sites: recent discoveries and treatment targets. (Q34939979) (← links)
- Discovery and computer aided potency optimization of a novel class of small molecule CXCR4 antagonists (Q35036663) (← links)
- Targeting tumor cell motility to prevent metastasis. (Q35095152) (← links)
- The prognostic value of CXCR4 in ovarian cancer: a meta-analysis (Q35127922) (← links)
- Downregulation of CXCR4 in Metastasized Breast Cancer Cells and Implication in Their Dormancy (Q35666361) (← links)
- Prognostic value of stromal cell-derived factor 1 expression in patients with gastric cancer after surgical resection (Q35713406) (← links)
- SDF-1alpha concentration dependent modulation of RhoA and Rac1 modifies breast cancer and stromal cells interaction. (Q35732102) (← links)
- Process of hepatic metastasis from pancreatic cancer: biology with clinical significance (Q35739397) (← links)
- Antileukemia activity of the novel peptidic CXCR4 antagonist LY2510924 as monotherapy and in combination with chemotherapy (Q35836868) (← links)
- The mesenchymal tumor microenvironment: a drug-resistant niche (Q36187755) (← links)
- Radiation-induced lung damage promotes breast cancer lung-metastasis through CXCR4 signaling (Q36413560) (← links)
- The Role of chemokine receptor CXCR4 in breast cancer metastasis (Q36562896) (← links)
- Targeting CXCL12/CXCR4 signaling with oncolytic virotherapy disrupts tumor vasculature and inhibits breast cancer metastases (Q36747524) (← links)
- Trial Watch-Small molecules targeting the immunological tumor microenvironment for cancer therapy (Q37079141) (← links)
- Difference in CXCR4 expression between sporadic and VHL-related hemangioblastoma (Q37231081) (← links)
- CXCR4 inhibitors could benefit to HER2 but not to triple-negative breast cancer patients (Q37685449) (← links)
- Antiangiogenic therapy, hypoxia, and metastasis: risky liaisons, or not? (Q37883011) (← links)
- Emerging targeted agents in metastatic breast cancer (Q38086421) (← links)
- Specific protein markers for stem cell cross-talk with neighboring cells in the environment (Q38175402) (← links)
- Targeting vascular and leukocyte communication in angiogenesis, inflammation and fibrosis. (Q38650120) (← links)
- Identification and analysis of CXCR4-positive synovial sarcoma-initiating cells (Q38814109) (← links)
- Breaking the crosstalk of the cellular tumorigenic network: Hypothesis for addressing resistances to targeted therapies in advanced NSCLC. (Q38840383) (← links)
- CXCR4 inhibition with AMD3100 sensitizes prostate cancer to docetaxel chemotherapy (Q39284720) (← links)
- Hybrid peptide dendrimers for imaging of chemokine receptor 4 (CXCR4) expression. (Q39442795) (← links)
- CXC and CC chemokines as angiogenic modulators in nonhaematological tumors. (Q40724369) (← links)
- Long non-coding RNAs as novel biomarkers for breast cancer invasion and metastasis (Q41143566) (← links)
- Crucial microRNAs and genes of human primary breast cancer explored by microRNA-mRNA integrated analysis. (Q41438471) (← links)
- CXCR4 knockdown inhibits the growth and invasion of nasopharyngeal cancer stem cells (Q42033255) (← links)
- Discovery of novel N-aryl piperazine CXCR4 antagonists (Q42144564) (← links)
- Posttranscriptional control of the chemokine receptor CXCR4 expression in cancer cells. (Q42845461) (← links)
- Targeting CXCL12/CXCR4 Axis in Tumor Immunotherapy (Q47850217) (← links)
- High expression of SDF-1 and VEGF is associated with poor prognosis in patients with synovial sarcomas (Q49875919) (← links)
- Breast cancer metastasis to liver and lung is facilitated by Pit-1-CXCL12-CXCR4 axis (Q50100841) (← links)
- Promise of chemokine network-targeted nanoparticles in combination nucleic acid therapies of metastatic cancer. (Q52559698) (← links)
- CXCR4 antagonists for treatment of breast cancer (Q57493691) (← links)
- GPCR Modulation in Breast Cancer (Q60921607) (← links)
- CXCR4 inhibition enhances radiosensitivity, while inducing cancer cell mobilization in a prostate cancer mouse model (Q87652766) (← links)
- Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trial (Q88506076) (← links)
- Recruitment of Intratumoral CD103+ Dendritic Cells by a CXCR4 Antagonist-Armed Virotherapy Enhances Antitumor Immunity (Q92436840) (← links)
- Bone Metastasis of Breast Cancer (Q92917018) (← links)